Fig. 1
From: Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
Genomic mutation landscape in cholangiocarcinoma distinguished by MSI status. A Genetic profile of significantly altered genes and associated clinicopathological characteristics of all 887 cholangiocarcinoma patients. Only the top 20 altered genes and top 10 pathways of the MSI-H group are shown. B The TMB value in the MSI-H group was significantly higher than that in the MSS group. MSI-H, microsatellite instability-high; MSS, microsatellite stability; TMB, tumor mutation burden